Warning: The NCBI web site requires JavaScript to function. more...
Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease.
Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H, Metzger J.
J Proteome Res. 2009 Jan;8(1):268-81.PMID: 19012428 [PubMed - indexed for MEDLINE]Related articles
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
Schjoedt KJ, Astrup AS, Persson F, Frandsen E, Boomsma F, Rossing K, Tarnow L, Rossing P, Parving HH.
Diabetologia. 2009 Jan;52(1):46-9. Epub 2008 Oct 31.PMID: 18974967 [PubMed - indexed for MEDLINE]Related articles
Urinary proteomics in diabetes and CKD.
Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P; PREDICTIONS Network.
J Am Soc Nephrol. 2008 Jul;19(7):1283-90. Epub 2008 Apr 30.PMID: 18448586 [PubMed - indexed for MEDLINE]Related articlesFree article
Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
Rossing K.
Dan Med Bull. 2007 May;54(2):79-98. Review. No abstract available. PMID: 17521525 [PubMed - indexed for MEDLINE]Related articles
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.
Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Tarnow L, Rossing P, Parving HH.
Kidney Int. 2006 Aug;70(3):536-42. Epub 2006 Jun 14.PMID: 16775595 [PubMed - indexed for MEDLINE]Related articles
Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH.
Diabetes Care. 2006 May;29(5):1024-30.PMID: 16644632 [PubMed - indexed for MEDLINE]Related articlesFree article
Anaemia in diabetes: Is there a rationale to TREAT?
Thomas MC, Cooper ME, Rossing K, Parving HH.
Diabetologia. 2006 Jun;49(6):1151-7. Epub 2006 Apr 4. Review.PMID: 16586069 [PubMed - indexed for MEDLINE]Related articles
Beneficial impact of spironolactone in diabetic nephropathy.
Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving HH.
Kidney Int. 2005 Dec;68(6):2829-36.PMID: 16316360 [PubMed - indexed for MEDLINE]Related articles
Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.
Rossing K, Christensen PK, Hovind P, Parving HH.
Diabetologia. 2005 Nov;48(11):2241-7. Epub 2005 Sep 17.PMID: 16170513 [PubMed - indexed for MEDLINE]Related articles
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.
Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH.
Diabetes Care. 2005 Sep;28(9):2106-12.PMID: 16123474 [PubMed - indexed for MEDLINE]Related articlesFree article
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria.
Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving HH.
Kidney Int. 2005 Sep;68(3):1190-8.PMID: 16105050 [PubMed - indexed for MEDLINE]Related articles
Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns.
Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T.
Kidney Int. 2005 Jul;68(1):193-205.PMID: 15954909 [PubMed - indexed for MEDLINE]Related articles
Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH.
Horm Metab Res. 2005 Apr;37 Suppl 1:4-8.PMID: 15918104 [PubMed - indexed for MEDLINE]Related articles
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.
Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH.
Kidney Int. 2005 Jun;67(6):2325-9.PMID: 15882275 [PubMed - indexed for MEDLINE]Related articles
Progression of nephropathy in type 2 diabetic patients.
Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.
Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
Jacobsen P, Rossing K, Parving HH.
Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. Review.PMID: 15073491 [PubMed - indexed for MEDLINE]Related articles
Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.
Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L.
Semin Nephrol. 2004 Mar;24(2):147-57. Review.PMID: 15017527 [PubMed - indexed for MEDLINE]Related articles
Effect of short-term hyperglycaemia on haemodynamics in type 1 diabetic patients.
Jacobsen P, Rossing K, Hansen BV, Bie P, Vaag A, Parving HH.
J Intern Med. 2003 Nov;254(5):464-71.PMID: 14535968 [PubMed - indexed for MEDLINE]Related articles
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Rossing K, Jacobsen P, Pietraszek L, Parving HH.
Diabetes Care. 2003 Aug;26(8):2268-74.PMID: 12882847 [PubMed - indexed for MEDLINE]Related articlesFree article
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH.
Kidney Int. 2003 May;63(5):1874-80.PMID: 12675866 [PubMed - indexed for MEDLINE]Related articles
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.
Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH.
Diabetes Care. 2003 Apr;26(4):1258-64.PMID: 12663607 [PubMed - indexed for MEDLINE]Related articlesFree article
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria study.
Rossing K, Christensen PK, Andersen S, Hovind P, Hansen HP, Parving HH; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study.
Diabetes Care. 2003 Mar;26(3):569-74.PMID: 12610003 [PubMed - indexed for MEDLINE]Related articlesFree article
Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study.
Rossing K, Christensen PK, Hansen BV, Carstensen B, Parving HH.
Diabetes Care. 2003 Jan;26(1):150-5.PMID: 12502672 [PubMed - indexed for MEDLINE]Related articlesFree article
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.
Jacobsen P, Andersen S, Rossing K, Hansen BV, Parving HH.
Nephrol Dial Transplant. 2002 Jun;17(6):1019-24.PMID: 12032191 [PubMed - indexed for MEDLINE]Related articlesFree article
Pregnancy and progression of diabetic nephropathy.
Rossing K, Jacobsen P, Hommel E, Mathiesen E, Svenningsen A, Rossing P, Parving HH.
Diabetologia. 2002 Jan;45(1):36-41.PMID: 11845221 [PubMed - indexed for MEDLINE]Related articles
Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
Rossing K, Christensen PK, Jensen BR, Parving HH.
Diabetes Care. 2002 Jan;25(1):95-100.PMID: 11772908 [PubMed - indexed for MEDLINE]Related articlesFree article
Evolving strategies for renoprotection: diabetic nephropathy.
Parving HH, Hovind P, Rossing K, Andersen S.
Curr Opin Nephrol Hypertens. 2001 Jul;10(4):515-22. Review.PMID: 11458033 [PubMed - indexed for MEDLINE]Related articles
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy.
Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B.
Diabet Med. 2000 Sep;17(9):644-9.PMID: 11051283 [PubMed - indexed for MEDLINE]Related articles
Progression of diabetic nephropathy in normotensive type 1 diabetic patients.
Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH.
Kidney Int Suppl. 1999 Jul;71:S101-5.PMID: 10412749 [PubMed - indexed for MEDLINE]Related articles
Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy.
Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, Parving HH.
Diabetes Care. 1998 Nov;21(11):2007-15.PMID: 9802759 [PubMed - indexed for MEDLINE]Related articlesFree article
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, Cambien F, Parving HH.
Kidney Int. 1998 Apr;53(4):1002-6.PMID: 9551410 [PubMed - indexed for MEDLINE]Related articlesFree article
Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients.
Clausen P, Feldt-Rasmussen B, Jacobsen P, Rossing K, Parving HH, Nielsen PK, Feldt-Rasmussen U, Olgaard K.
Diabet Med. 1997 Dec;14(12):1038-43.PMID: 9455931 [PubMed - indexed for MEDLINE]Related articles
[Diabetic nephropathy. Unchanged occurrence in patients with insulin-dependent diabetes mellitus]
Rossing P, Rossing K, Jacobsen P, Parving HH.
Ugeskr Laeger. 1996 Oct 14;158(42):5940-3. Danish. PMID: 8928282 [PubMed - indexed for MEDLINE]Related articles
The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria.
Hansen HP, Rossing K, Jacobsen P, Jensen BR, Parving HH.
Scand J Clin Lab Invest. 1996 Aug;56(5):393-9.PMID: 8869661 [PubMed - indexed for MEDLINE]Related articles
Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy.
Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P.
Kidney Int. 1996 Jun;49(6):1778-82.PMID: 8743496 [PubMed - indexed for MEDLINE]Related articles
Unchanged incidence of diabetic nephropathy in IDDM patients.
Diabetes. 1995 Jul;44(7):739-43.PMID: 7789641 [PubMed - indexed for MEDLINE]Related articles
Filter your results:
J Am Soc Nephrol. 2008 Jul; 19(7):1283-90.
[J Am Soc Nephrol. 2008]
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...